Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
暂无分享,去创建一个
J. Baselga | M. Climent | W. Eiermann | A. Lluch | V. Semiglazov | A. Manikhas | L. Gianni | M. Lichinitser | Roberta Baronio | P. Valagussa | M. Zambetti | E. Ciruelos | A. Feyereislova | Mikhail Byakhow | F. Vázquez | B. Ojeda | S. Tjulandin | C. Barton | M. Mansutti | A. Bozhok